Dianthus Therapeutics, Inc. (DNTH) Profit Margins
Over the twelve months to 2026-06-30, Dianthus Therapeutics, Inc. (DNTH) had operating margin -11441.4%, net margin -10097.0%, free cash flow margin -8178.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DNTHDianthus Therapeutics, Inc.Follow DNTH — free
—
Price chart with a free account
- Market cap
- 4.3B
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Operating margin | -1704.7% | -1633.7% | -8739.3% | -11441.4% | |
| Net margin | -1541.2% | -1362.8% | -7973.3% | -10097.0% | |
| FCF margin | -1308.2% | -1255.6% | -6349.4% | -8178.0% |
USD billions · SEC XBRL
Dianthus Therapeutics, Inc. — questions
- What is Dianthus Therapeutics, Inc.'s operating margin?
- -11441.4% over the twelve months to 2026-06-30.
- What is Dianthus Therapeutics, Inc.'s net profit margin?
- -10097.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Dianthus Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.